Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Microsoft: Ransomware hit nearly 400 healthcare entities this year—a 300% rise since 2015
A study from Microsoft on the impact of ransomware found unaffected nearby hospitals see a rise in stroke and cardiac arrest cases, in addition to an influx of patients.
10 ways AI, robotics are improving pediatric care in real-world settings
For whatever reason, the grownups seem to get all the attention when talk turns to AI in healthcare. All the kiddos get to do is look on and listen in. Now comes a worthy little effort to balance the seesaw.
Feds make it official: Change data breach was the largest in healthcare history, impacting 100M
Updated reporting from HHS shows UnitedHealth Group's estimate that roughly one-third of people in the U.S. would be affected was correct.
FDA approves first RSV vaccine for adults
Pfizer's Abrysvo vaccine can now be prescribed to all adults 18 and older at high risk for severe RSV complications, including pregnant women.
Blue Cross Blue Shield of New York sued over ‘ghost networks’
Thousands of patients have filed a class-action lawsuit against the insurer for issuing directories of providers who were out-of-network and did not take BCBS health plans.

Intermountain CEO: Hospital-run generics company may include 1,000+ facilities

The goal of a hospital-run generic drug company is to combat “non-competitive activity” among current generic pharmaceuticals, according to Marc Harrison, MD, CEO of one of the founding companies, Intermountain Healthcare.

February 2, 2018

ACA repeal not on Republican agenda for 2018

The priorities for Republicans in Congress this year don’t appear to include another attempt at repealing and replacing the Affordable Care Act (ACA), though some are publicly urging the party to take another shot after several failed attempts in 2017.

February 2, 2018

Justice Department requests more info on CVS-Aetna merger

The $69 billion proposed acquisition of Aetna by CVS Health remains under review by the Department of Justice (DOJ), which requested the companies provide more information on their merger agreement.

February 2, 2018

How Idaho’s insurance plan would violate ACA

The Idaho Department of Insurance has announced it will allow insurers to sell plans which don’t comply with regulations established by the Affordable Care Act (ACA), which could mean the return of plans that deny coverage based on pre-existing conditions, charge higher premiums based on health status and place lifetime or annual caps on benefits.

February 2, 2018

5 things to know about proposed MA rates, Part D changes for 2019

CMS has released its proposed rule covering rates in Medicare Advantage (MA) and changes to Medicare Part D for 2019, expanding the definition of health-related supplemental benefits and putting limits on opioid prescriptions for beneficiaries.

February 2, 2018

Indicted interim CEO picked to lead Broward Health

The board for the five-hospital Broward Health in Fort Lauderdale, Florida, was supposed to pick the system’s new CEO from a group of four finalists, ending a two-year executive search. Instead, it selected interim CEO Beverly Capasso, who is currently indicted on charges of breaking the state’s open meetings law in firing her predecessor as interim CEO.

February 1, 2018

Wasteful healthcare spending totaled $282M in Washington state

In a single year, more than 600,000 patients in Washington state received services that would be considered low value or wasteful, resulting in $282 million in unnecessary healthcare spending.

February 1, 2018

Hospitals can expect 7.35% increase in drug prices

Between July 1, 2018, and June 30, 2019, health systems should expect pharmaceutical prices to jump up by 7.35 percent, a slightly lower increase than in recent years as fewer products see “exorbitant” price hikes and costs moderate for high-priced hepatitis C drugs.

February 1, 2018

Around the web

Cardiovascular Business

Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.

Cardiovascular Business

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.

Management

Microsoft: Ransomware hit nearly 400 healthcare entities this year—a 300% rise since 2015

10 ways AI, robotics are improving pediatric care in real-world settings

Feds make it official: Change data breach was the largest in healthcare history, impacting 100M

FDA approves first RSV vaccine for adults

Blue Cross Blue Shield of New York sued over ‘ghost networks’

Around the web